Works matching IS 25896113 AND DT 2023 AND VI 6 AND IP 3
Results: 2
How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?
- Published in:
- Glioma (2589-6113), 2023, v. 6, n. 3, p. 29, doi. 10.4103/glioma.glioma_8_23
- By:
- Publication type:
- Article
Gliosarcoma in a patient with triple-negative breast cancer: A case report.
- Published in:
- Glioma (2589-6113), 2023, v. 6, n. 3, p. 23, doi. 10.4103/glioma.glioma_7_23
- By:
- Publication type:
- Article